Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Liver Cirrhosis

  Free Subscription

Articles published in Dig Dis

Retrieve available abstracts of 28 articles:
HTML format

Single Articles

    March 2024
  1. LEMMER P, Rohr LC, Henning M, Bulut K, et al
    Liver stiffness determined by transient elastography is a simple and highly accurate predictor for presence of liver cirrhosis in clinical routine.
    Dig Dis. 2024 Mar 25. doi: 10.1159/000538426.
    PubMed     Abstract available

    January 2024
  2. WU PS, Hsieh YC, Lee PC, Yang TC, et al
    Mac-2 Binding Protein Glycosylation Isomer to Albumin Ratio Predicts Bacterial Infections in Cirrhotic Patients.
    Dig Dis. 2024 Jan 12. doi: 10.1159/000535325.
    PubMed     Abstract available

    September 2023
  3. TAN D, Chan KE, Wong ZY, Ng CH, et al
    Global Epidemiology of Cirrhosis: Changing Etiological Basis and Comparable Burden of NASH between Males and Females.
    Dig Dis. 2023 Sep 13. doi: 10.1159/000533946.
    PubMed     Abstract available

    July 2023
  4. KEKLIKKIRAN C, Stepanova M, Younossi Z, Yilmaz Y, et al
    Can Frequent Toothbrushing Reduce the Risk of Cirrhosis among Patients with Non-alcoholic Fatty Liver Disease? Hints from a Registry-based Study.
    Dig Dis. 2023 Jul 26. doi: 10.1159/000531981.
    PubMed     Abstract available

    June 2023
  5. TAMURA Y, Asaoka Y, Takeuchi A, Matsumoto K, et al
    Long-Term Prognosis and Related Factors in Patients with Cirrhosis Treated with Balloon-Occluded Retrograde Transvenous Obliteration.
    Dig Dis. 2023 Jun 29:1-9. doi: 10.1159/000530781.
    PubMed     Abstract available

  6. CHEN Q, Zhong R, Wang Y, Kui Y, et al
    The Albumin-Bilirubin Score as a Predictor of Liver-Related Mortality in Primary Biliary Cholangitis with Compensated Cirrhosis.
    Dig Dis. 2023 Jun 15. doi: 10.1159/000531557.
    PubMed     Abstract available

    May 2023
  7. QUEK J, Tan DJH, Chan KE, Lim WH, et al
    Quality Assessment of Ultrasound and Magnetic Resonance Imaging for Hepatocellular Carcinoma Surveillance: Systematic Review and Meta-Analysis.
    Dig Dis. 2023 May 11:1. doi: 10.1159/000531016.
    PubMed     Abstract available

    April 2023
  8. WANG SQ, Zhan YQ, Hu X, Zhuang YP, et al
    Anemia is associated with disease severity, hepatic complications, and progression of Wilson disease: a retrospective cohort study.
    Dig Dis. 2023 Apr 5. doi: 10.1159/000530473.
    PubMed     Abstract available

    January 2023
  9. HUANG DQ, Lee DH, Le MH, Le A, et al
    Liver Complications in Untreated Treatment-Ineligible versus Treated Treatment-Eligible Patients with Hepatitis B.
    Dig Dis. 2023;41:115-123.
    PubMed     Abstract available

  10. FERRARI-CESTARI M, Okano S, Patel PJ, Horsfall LU, et al
    Serum CC-Chemokine Ligand 2 Is Associated with Visceral Adiposity but Not Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease.
    Dig Dis. 2023;41:439-446.
    PubMed     Abstract available

  11. PENG S, Wu Q, Huang X, He X, et al
    Diagnostic Value of Serum Golgi Protein 73 for Liver Fibrosis: A Systematic Review and Meta-Analysis.
    Dig Dis. 2023;41:622-631.
    PubMed     Abstract available

  12. LE MH, Henry L, Cheung R, Nguyen MH, et al
    Transient Elastography and Serum-Based Tests for Diagnosis of Fatty Liver and Advanced Fibrosis in a Community Cohort: A Cross-Sectional Analysis.
    Dig Dis. 2023;41:767-779.
    PubMed     Abstract available

    March 2022
  13. SHI L, Zhang S
    Identification of subclasses of decompensated cirrhotic patients with acute kidney injury with different responses to fluid input.
    Dig Dis. 2022 Mar 17. pii: 000524028. doi: 10.1159/000524028.
    PubMed     Abstract available

    February 2022
  14. JAHN M, Raschidi L, Ozcurumez MK, Arzideh F, et al
    Comparison of Mortality Prediction Scores in Intermediate-Care Patients with Liver Cirrhosis at a German university transplant Center; a prospective study.
    Dig Dis. 2022 Feb 16. pii: 000522595. doi: 10.1159/000522595.
    PubMed     Abstract available

    January 2022
  15. MIJAC D, Krstic MN, Markovic AP, Popovic DD, et al
    Abnormal Liver Blood Tests: Primary Care Approach.
    Dig Dis. 2022;40:215-222.
    PubMed     Abstract available

    November 2021
  16. SHAO X, Uojima H, Arai T, Ogawa Y, et al
    The risk of cirrhosis and its complications based on PNPLA3 rs738409 G allele frequency.
    Dig Dis. 2021 Nov 22. pii: 000521062. doi: 10.1159/000521062.
    PubMed     Abstract available

    July 2021
  17. OSWALD L, Nakanishi H, Kurosaki M, Kirino S, et al
    Plasma renin activity predicts prognosis and liver disease-related events in liver cirrhosis patients with ascites treated by tolvaptan.
    Dig Dis. 2021 Jul 30. pii: 000518099. doi: 10.1159/000518099.

    June 2021
  18. KUBOTA K, Uojima H, Shao X, Iwasaki S, et al
    Additional L-carnitine Reduced the Risk of Hospitalization in Patients with Overt Hepatic Encephalopathy on Rifaximin.
    Dig Dis. 2021 Jun 28. pii: 000518067. doi: 10.1159/000518067.

    May 2021
  19. KRSTIC MN, Mijac D, Tomasevic RS, Lukic S, et al
    Abnormal liver blood tests: Hepatologist approach.
    Dig Dis. 2021 May 10. pii: 000517110. doi: 10.1159/000517110.

    April 2021
  20. MEYER JJ, Dreyhaupt J, Schwerdel D, Ettrich TJ, et al
    Blood-based targeted metabolomics discriminate patients with alcoholic liver cirrhosis from those with non-cirrhotic liver damage: an explorative study.
    Dig Dis. 2021 Apr 16. pii: 000516488. doi: 10.1159/000516488.

  21. MANZHALII E, Falalyeyeva TM, Moyseyenko VO, Weiskirchen R, et al
    Elevation of autoantibodies to cerebral proteins in hepatic encephalopathy: Another pathogenic factor?
    Dig Dis. 2021 Apr 9. pii: 000516412. doi: 10.1159/000516412.
    PubMed     Abstract available

    January 2021
  22. KUSNIK A, Hunter N, Rasbach E, Miethke T, et al
    Co-Medication and nutrition in HCC: Potentially preventative strategies in Hepatocellular carcinoma (HCC).
    Dig Dis. 2021 Jan 11. pii: 000514277. doi: 10.1159/000514277.
    PubMed     Abstract available

  23. PARK J, Lee EY, Li J, Jun MJ, et al
    NASH/Liver Fibrosis Prevalence and Incidence of Nonliver Comorbidities among People with NAFLD and Incidence of NAFLD by Metabolic Comorbidities: Lessons from South Korea.
    Dig Dis. 2021;39:634-645.
    PubMed     Abstract available

  24. FREITAS M, Macedo Silva V, Xavier S, Magalhaes J, et al
    Early Kidney Dysfunction in Metabolic-Associated Fatty Liver Disease: Is Transient Elastography Useful as a Screening Method?
    Dig Dis. 2021;39:653-662.
    PubMed     Abstract available

  25. ATTA S, Kamel M, Mansour W, Hussein T, et al
    Ascitic Fluid Cytokines in Chronic Liver Disease: A Possible Prognostic Tool.
    Dig Dis. 2021;39:534-539.
    PubMed     Abstract available

    November 2020
  26. WEN M, Men R, Fan X, Shen Y, et al
    Worse Response to Ursodeoxycholic Acid in Primary Biliary Cholangitis Patients with Autoimmune Hepatitis Features.
    Dig Dis. 2020 Nov 25. pii: 000513331. doi: 10.1159/000513331.
    PubMed     Abstract available

  27. IDILMAN R, Aydogan M, Oruncu MB, Kartal A, et al
    Dig Dis. 2020 Nov 3. pii: 000512746. doi: 10.1159/000512746.
    PubMed     Abstract available

    March 2020
  28. MILOVANOVIC T, Popovic D, Stojkovic Lalosevic M, Dumic I, et al
    Quality Of Life in Patients With Primary Biliary Cholangitis: A Single Center Experience in Serbia.
    Dig Dis. 2020 Mar 6. pii: 000506980. doi: 10.1159/000506980.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Liver Cirrhosis is free of charge.